Haemonetics Competitors and Similar CompaniesClear all
Haemonetics's competitors and similar companies include Zimmer Biomet and Glaukos.
 Zimmer Biomet Zimmer Biomet Holdings is a medical technology company that develops implants and digital technologies. |  Glaukos Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. | ||
Founding Date | Founding Date 1971 | Founding Date 1927 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Aliso Viejo, US HQ Buenos Aires, AR Heatherton, AU Sao Paulo, BR Richmond Hill, CA San José, CR Wiesbaden, DE see more | ||
Employees | Employees 3,65721% increase | Employees 18,000 | Employees 90716% increase |
Valuation ($) | Valuation ($) 3.7 b | Valuation ($) 21.2 b | Valuation ($) 7.6 b |
Financial | |||
Revenue (est.) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $7.7b (FY, 2024) | Revenue (est.) $383.5m (FY, 2024) |
Cost of goods | Cost of goods $611.9m (FY, 2025) | Cost of goods $2.2b (FY, 2024) | Cost of goods $94m (FY, 2024) |
Gross profit | Gross profit $749m (FY, 2025) | Gross profit $5.5b (FY, 2024) | Gross profit $289.5m (FY, 2024) |
Net income | Net income $167.7m (FY, 2025) | Net income $905.3m (FY, 2024) | Net income ($146.4m) (FY, 2024) |
Operating ⚠ | |||
Facility Space Leased, sq. ft. | Facility Space Leased, sq. ft. 885.4 k (FY, 2023) | Facility Space Leased, sq. ft. N/A | Facility Space Leased, sq. ft. 318 k (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 1b | Total funding raised $ 115m |
For sources of this data, please see the company profile
View Company Profiles
Zimmer Biomet
HQ
Warsaw, US
Employees
18,000
Zimmer Biomet Holdings is a medical technology company that develops implants and digital technologies.
View companyGlaukos
HQ
Aliso Viejo, US
Employees
907↑ 16% increase
Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases.
View company